{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T14:01:26Z","timestamp":1780408886560,"version":"3.54.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ad.2026.104605","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T16:40:20Z","timestamp":1773074420000},"page":"104605","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cutaneous Clearance in a Patient With Xeroderma Pigmentosum Under Treatment With Nivolumab"],"prefix":"10.1016","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-3198-8625","authenticated-orcid":false,"given":"X.","family":"Atxutegi Ayesta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4155-0581","authenticated-orcid":false,"given":"J.M.","family":"Villa-Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Ocerin Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Gardeazabal Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2026.104605_bib0055","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-016-0408-0","article-title":"Uncommon nucleotide excision repair phenotypes revealed by targeted high-throughput sequencing","volume":"11","author":"Calmels","year":"2016","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ad.2026.104605_bib0060","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.18632\/oncotarget.27966","article-title":"Immunotherapy in Xeroderma Pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review","volume":"12","author":"Rubatto","year":"2021","journal-title":"Oncotarget"},{"key":"10.1016\/j.ad.2026.104605_bib0065","article-title":"Xeroderma pigmentosum: an updated review","volume":"11","author":"Leung","year":"2022","journal-title":"Drugs Contest"},{"key":"10.1016\/j.ad.2026.104605_bib0070","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/bjd.16270","article-title":"Efficacy of anti-programmed cell death-1 immunotherapy for skin carcinomas and melanoma metastases in a patient with xeroderma pigmentosum","volume":"178","author":"Salomon","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2026.104605_bib0075","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ejca.2022.06.050","article-title":"Three-year disease-free remission in a xeroderma pigmentosum patient after adjuvant anti-PD-1 therapy","volume":"173","author":"Scheer","year":"2022","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ad.2026.104605_bib0080","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1282823","article-title":"Retrospective study of efficacy and adverse events of immune checkpoint inhibitors in 22 xeroderma pigmentosum patients with metastatic or unresectable cancers","volume":"13","author":"Fernandez","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.ad.2026.104605_bib0085","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejca.2017.02.026","article-title":"Regression of melanoma metastases and multiple non-melanoma skin cancers in xeroderma pigmentosum by the PD1-antibody pembrolizumab","volume":"77","author":"Hauschild","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ad.2026.104605_bib0090","first-page":"312","article-title":"Successful use of anti-PD-1 antibody to treat multiple metastatic carcinomas in a patient with xeroderma pigmentosum: case report and literature review","volume":"5","author":"Itoyama","year":"2023","journal-title":"Clin Image Case Rep J"},{"key":"10.1016\/j.ad.2026.104605_bib0095","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1046\/j.1365-2133.2003.05613.x","article-title":"Excellent response of basal cell carcinomas and pigmentary changes in xeroderma pigmentosum to imiquimod 5% cream","volume":"149","author":"Nagore","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2026.104605_bib0100","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/ajd.14029","article-title":"Imiquimod chemoprophylaxis for field cancerization in xeroderma pigmentosum patients \u2013 a prospective study","volume":"64","author":"Rocha","year":"2023","journal-title":"Australas J Dermatol"}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731026000153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731026000153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T13:03:22Z","timestamp":1780405402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731026000153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0001731026000153"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2026.104605","relation":{},"ISSN":["0001-7310"],"issn-type":[{"value":"0001-7310","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cutaneous Clearance in a Patient With Xeroderma Pigmentosum Under Treatment With Nivolumab","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2026.104605","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 AEDV. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"104605"}}